- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04679532
NBA G-League Sweat Testing Study: Validity of the Gx Sweat Patch in Measuring Sweating Rate and Sweat Chloride Concentration During On-court Training With Basketball Players
June 22, 2022 updated by: PepsiCo Global R&D
To determine the validity of the Gx Sweat Patch in measuring sweating rate and sweat chloride concentration during moderate-high intensity practice against well-established reference methods in field conditions with basketball athletes
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
65
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Walnut Creek, California, United States, 94598
- NBA G League Ignite Team Site Ultimate Fieldhouse, 2675 Mitchell Dr.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- 18-40 years of age
- Subject is participating in training/competition with the NBA G-league
- Subject is participating in a coach led practice
Exclusion Criteria:
- Subject has an allergy to adhesives (e.g., experiences rash reactions to typical adhesive bandages)
- Subject has participated in a clinical trial within past 30 days
- Subject has participated in any PepsiCo trial within past 6 months
- Subject has a condition the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Validation. Gx sweat collection patch
Left ventral forearm placement using Epicore Biosystems Gx patch
|
Adhesive-backed flexible epidermal wearable regional sweat patch to collect and analyze sweat via microfluidics and colorimetric assay
|
OTHER: Validation. Reference sweat collection patch
Right ventral forearm placement using a well-established methodology as published in peer-reviewed journals
|
Adhesive Tegaderm with absorbent pad regional sweat patch to collect sweat, followed by standard benchtop gravimetry and ion chromatography methods to analyze sweat
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Regional sweat chloride concentration
Time Frame: Average across a single practice session on 1 day
|
Gx patch vs. reference patch during exercise.
Gx patch analyzed by colorimetry via smartphone app.
Reference patch analyzed with ion chromatography
|
Average across a single practice session on 1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Regional sweating rate
Time Frame: Average across the same single practice session on the same 1 day as the primary outcome
|
Gx patch vs. reference patch during exercise.
Gx patch analyzed by microfluidic reading with Smartphone.
Reference patch analyzed with gravimetry
|
Average across the same single practice session on the same 1 day as the primary outcome
|
Whole body sweating rate
Time Frame: Measured one time to represent the average across the same single practice session on the same 1 day as the primary outcome
|
Change in body mass from pre- to post-exercise, corrected for fluid/food intake and urine loss.
Body mass measured to the nearest 0.01 kg using a digital platform scale
|
Measured one time to represent the average across the same single practice session on the same 1 day as the primary outcome
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lindsay B Baker, PhD, PepsiCo Global R&D, Gatorade Sports Science Institute (GSSI) Barrington, IL
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 8, 2020
Primary Completion (ACTUAL)
November 4, 2021
Study Completion (ACTUAL)
November 4, 2021
Study Registration Dates
First Submitted
December 9, 2020
First Submitted That Met QC Criteria
December 17, 2020
First Posted (ACTUAL)
December 22, 2020
Study Record Updates
Last Update Posted (ACTUAL)
June 23, 2022
Last Update Submitted That Met QC Criteria
June 22, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PEP-2001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sweat Analysis
-
Medacta International SAActive, not recruiting
-
University of South FloridaCompleted
-
University GhentHasselt University; Maastricht UniversityRecruitingGait Analysis | ReproducibilityNetherlands, Belgium
-
Hospital for Special Surgery, New YorkCompletedBlood Volume AnalysisUnited States
-
University of California, Los AngelesOlive View-UCLA Education & Research InstituteUnknown
-
Keimyung University Dongsan Medical CenterCompletedAnalysis, Event History
-
University Hospital, Clermont-FerrandCompleted
-
Olive View-UCLA Education & Research InstituteCompleted
Clinical Trials on Gx sweat patch
-
Candesant Biomedical, Inc.CompletedPrimary Axillary HyperhidrosisUnited States
-
PepsiCo Global R&DCompletedFluid Intake in Athletes | Sweating Rate in Athletes | Sweat Chloride Concentration in AthletesUnited States
-
Cliniques universitaires Saint-Luc- Université...Université de LiègeRecruitingCystic Fibrosis | BiomarkersBelgium
-
Northwestern UniversityCompleted
-
University Hospital, GhentUniversity GhentTerminated
-
Yonsei UniversityRecruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalUnknown
-
Genexine, Inc.CompletedLocally Advanced or Metastatic Solid TumorsKorea, Republic of
-
Genexine, Inc.UnknownCervical Intraepithelial Neoplasia 3Korea, Republic of